VENTAVIS

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug VENTAVIS contains one active pharmaceutical ingredient (API):

1 Iloprost trometamol UNII JED5K35YGL - ILOPROST

Iloprost is a synthetic prostacyclin analogue. After inhalation of iloprost direct vasodilatation of the pulmonary arterial bed occur with consecutive significant improvement of pulmonary artery pressure, pulmonary vascular resistance and cardiac output as well as mixed venous oxygen saturation. Read about Iloprost

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VENTAVIS Nebuliser solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC11	Iloprost	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5751Q, 6456T
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538902401131318
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.196-08-06
Country: EE	Ravimiamet	Identifier(s): 1205390, 1205402, 1205413, 1291890, 1291902, 1365027, 1662948, 1662959, 1701717, 1701728
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 03255004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 054388
Country: FR	Base de données publique des médicaments	Identifier(s): 66048871
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 113837, 357911, 365516, 372488, 379149
Country: IE	Health Products Regulatory Authority	Identifier(s): 88520
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4973
Country: IT	Agenzia del Farmaco	Identifier(s): 036019014, 036019026, 036019038, 036019040, 036019053, 036019091, 036019103, 036019115, 036019127, 036019139, 036019141
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190701G1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031155, 1031156, 1031157, 1031158, 1031159, 1034201, 1038374, 1038375, 1076821, 1076822, 1076823, 1076824, 1081753, 1081754
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 335M2006
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 127124, 132713
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12579
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100126548, 100145824
Country: SG	Health Sciences Authority	Identifier(s): 13140P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546754892, 8699546754908, 8699546754915, 8699546754922
Country: US	FDA, National Drug Code	Identifier(s): 66215-302, 66215-303